This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dr. Elliot Belenkov, Medical Oncology, Is Named A Top Doctor: New York Metro Area.

For more information on this Castle Connolly New York Metro Area Top Doctor®, please visit  Elliot Belenkov 's profile on www.castleconnolly.com.

Castle Connolly Medical Ltd.'s President and CEO Dr. John Connolly has this to say about Dr. Belenkov's recognition: "Roughly ten percent of area physicians were selected for our 16th edition of Top Doctors: New York Metro Area. Being nominated by Board Certified peers and then selected by our experts is an accomplishment worthy of recognition. The New York Metro area is home to a great number of very high quality medical professionals, yet some stand out. My congratulations to Dr. Belenkov."

To find out more or to contact Dr. Elliot Belenkov of New York, NY, please call 212-472-5500, or visit elliotbelenkov.com.

This press release was written by American Registry, LLC and Castle Connolly Medical Ltd., with approval by and/or contributions from Elliot Belenkov and was distributed by PR Newswire, a subsidiary of UBM plc.

Castle Connolly Medical Ltd. identifies top doctors in America and provides consumers with detailed information about their education, training and special expertise in printed guides and online directories. It is important to note that doctors do not and cannot pay to be included in any Castle Connolly guide or online directory. Learn more at http://www.castleconnolly.com.

American Registry, LLC, recognizes excellence in top businesses and professionals. For more information, search The Registry™ at  http://www.americanregistry.com.

Contact Info: Dr. Elliot Belenkov Phone: 212-472-5500Email Address: ebelenkov@gmail.comWebsite: elliotbelenkov.com

SOURCE American Registry

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs